Seshadri Vishwas — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Seshadri Vishwas has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.05M.

Profile

Vishwas Seshadri is the Chief Executive Officer and Director of Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for rare genetic diseases. He has been involved in the company's strategic direction and clinical programs, including therapies for conditions like recessive dystrophic epidermolysis bullosa.

Board memberships

• Abeona Therapeutics Inc.

Awards & honors

• Leadership in gene therapy development
• Strategic direction for clinical programs

Recent Transactions

Companies — Last 90 Days

• ABEONA THERAPEUTICS INC. (ABEO) — 2 filings, last 2026-07-09

Frequently Asked Questions

Who is Seshadri Vishwas?

Vishwas Seshadri is the Chief Executive Officer and Director of Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing gene therapies for rare genetic diseases. He has been involved in the company's strategic direction and clinical programs, including therapies for conditions like recessive dystrophic epidermolysis bullosa.…

How many SEC Form 4 filings has Seshadri Vishwas submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Seshadri Vishwas been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 10 open-market sales ($2.05M) across all tracked filings.

Where can I see all of Seshadri Vishwas's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week